Who Paid My Doc
P3 CIT For Solid Tumors Study 1
Research payments
$279,136
Through program year 2024, $279,136 in research payments was reported against P3 CIT For Solid Tumors Study 1, across 53 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $18,846 | 8 |
| 2023 | Research | $35,480 | 18 |
| 2022 | Research | $224,811 | 27 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Hanny Al-Samkari Boston, MA Named on 6 payments
- Christopher Snead Shreveport, LA Named on 5 payments
- Ajit Maniam Anaheim, CA Named on 4 payments
- Arvind Chaudhry Spokane, WA Named on 3 payments
- Viran Holden Springfield, MO Named on 3 payments
- Arun Nagarajan Weston, FL Named on 3 payments
- Zahra Pakbaz Orange, CA Named on 2 payments
- Hafez Halawani Alexandria, LA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.